Clinical Trial Update: Esmolol Infusion in Patients Undergoing Craniotomy [Phase 3]

View source ↗

Summary

Phase 3 trial of esmolol infusion in patients undergoing craniotomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Aneurysm
• Cerebral Arterial Disease

Drugs mentioned

• Esmolol (esmolol)

Snippet

Sponsor: George Papanicolaou Hospital | Conditions: Cerebral Arterial Disease, Cerebral Aneurysm | Phase 3 | Status: COMPLETED